Prof. Dr. SERDAL UĞURLU

Yayın Ağı

Makaleler 237

1. Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency

Aktas B., Parlar K., Senturk B., Saglam A., Dundar A., Uc C., et al.

Clinical Rheumatology , cilt.45, sa.2, ss.1257-1265, 2026 (SCI-Expanded, Scopus)

2. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Fidan S., ESATOĞLU S. N., ÖZGÜLER Y., UĞURLU S., SEYAHİ E., MELİKOĞLU M., et al.

Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

3. Familial Mediterranean Fever: A Comprehensive Review of Pathogenesis, Genetics, and Epigenetic Regulation

Uğurlu S., Kilinc O. C., Karacan İ., Parlar K.

Balkan Medical Journal , cilt.43, sa.1, ss.3-14, 2026 (SCI-Expanded, Scopus, TRDizin)

4. Impact of MEFV gene variants on clinical presentation in Familial Mediterranean Fever: A focus on Exon 2 mutations Impacto de las variantes del gen MEFV en la presentación clínica de la fiebre mediterránea familiar: enfoque en las mutaciones del exón 2

Kulaksiz B., Acar B., Kizilkaya O. O., Aktas B., UĞURLU S.

Reumatologia Clinica , cilt.22, sa.1, 2026 (ESCI, Scopus)

5. Certolizumab in Axial Spondyloarthritis: Persistence and Determinants

Aktas B., Azman E., Yüksel H. M., Erdogan B., Parlar K., Uc C., et al.

International Journal of Rheumatic Diseases , cilt.28, sa.6, 2025 (SCI-Expanded, Scopus)

6. Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis

KILIÇ B., Sacin E., Tanin M. K., Kilinc O. C., UĞURLU S.

Annals of Hematology , cilt.104, sa.5, ss.2617-2630, 2025 (SCI-Expanded, Scopus)

7. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications

Parlar K., Azman F. N., Sıcakyüz S. L., Rızaoğlu M., Azman E., Yüzbaşıoğlu M. B., et al.

Internal and Emergency Medicine , cilt.20, sa.3, ss.797-803, 2025 (SCI-Expanded, Scopus)

9. Rituximab intervention in management of thrombocytopenia in patients with systemic lupus erythematosus: A single centre experience

Toker Dincer Z., Acar B., Ersoy Y., Karali O., Azman F. N., Ammar T., et al.

Lupus , cilt.34, sa.3, ss.253-260, 2025 (SCI-Expanded, Scopus)

10. Rare C1q deficiency presenting as pediatric SLE: A case study of two consanguineous siblings

Parlar K., Aktaş B., Sicakyüz S. L., Şahin S., KASAPÇOPUR Ö., UĞURLU S.

REUMATOLOGIA CLINICA , cilt.21, sa.3, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

11. Fertility, pregnancy outcomes, and disease activity during pregnancy in patients with juvenile idiopathic arthritis: a descriptive study

Sonkurt A. I., Dogan G., Parlar K., Guler B., DEVECİ M., KASAPÇOPUR Ö., et al.

CLINICAL RHEUMATOLOGY , cilt.44, ss.789-797, 2025 (SCI-Expanded, Scopus)

12. Mimics and challenging presentations of DADA2

Öztürk A., Yagci L., UĞURLU S.

Clinical and Experimental Immunology , cilt.219, sa.1, 2025 (SCI-Expanded, Scopus)

13. VEXAS Syndrome: An Overlooked Threat

UĞURLU S., KILIÇ B.

Balkan Medical Journal , cilt.42, sa.3, ss.185-187, 2025 (SCI-Expanded, Scopus, TRDizin)

14. A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus

Firat Senturk E., Ayvaz B. B., FIRTINA S., UĞURLU S.

Lupus , cilt.34, sa.1, ss.108-114, 2025 (SCI-Expanded, Scopus)

15. Anakinra in the management of adult-onset still's disease: a single-center experience

Kilic B., Parlar K., Karup S., Ozturk A., Karaahmetli K., UĞURLU S.

INTERNAL AND EMERGENCY MEDICINE , cilt.20, sa.1, ss.131-138, 2025 (SCI-Expanded, Scopus)

16. A Complex TRAPS Case in a SLE Patient on Immunosuppressive Therapy Post-Organ Transplant

Aktas B., Parlar K., UĞURLU S.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.28, sa.1, 2025 (SCI-Expanded, Scopus)

17. Rituximab Treatment in Lupus Nephritis Resistant to Conventional Therapy: A Single-Centre Experience

Senturk E. F., Ogun H., DURUCAN İ., Yurttas B., UĞURLU S.

Mediterranean Journal of Rheumatology , cilt.36, sa.2, ss.229-235, 2025 (Scopus)

18. Targeting complement dysregulation: eculizumab in scleroderma renal crisis management-a case-based review

TOKER DİNÇER Z., DİNÇER M. T., Sen G., UĞURLU S., SEYAHİ N., SEYAHİ E.

RHEUMATOLOGY INTERNATIONAL , cilt.44, sa.12, ss.3135-3140, 2024 (SCI-Expanded, Scopus)

19. Characteristics of arthritis in patients with familial Mediterranean fever

Yenigun S., Ayla A. Y., Yuzbasioglu M. B., Baspinar S. N., Ergun S., Karabicek A., et al.

Internal Medicine Journal , cilt.54, sa.11, ss.1802-1808, 2024 (SCI-Expanded, Scopus)

20. EXPLORING S100A8/A9, NEOPTERIN, AND MMP3 IN FAMILIAL MEDITERRANEAN FEVER: INSIGHTS INTO PATHOGENESIS AND DIAGNOSTIC SIGNIFICANCE

Kilinc O. C., AKDENİZ Y. S., Taskin Z., Karabulut M., Kaya A., BOLAYIRLI İ. M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

21. REFRACTORY SWEET SYNDROME IN ASSOCIATION WITH FAMILIAL MEDITERRANEAN FEVER: A CASE REPORT

TOKER DİNÇER Z., Azman F. N., UĞURLU S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

22. A rare case of uncharacterized autoinflammatory disease: Patient carrying variations in NLRP3 and TNFRSF1A genes

Kilinc O. C., Gayibova K., Onen M. O., ONAT U. İ., Bülbül A., TİMUÇİN A. C., et al.

American Journal of Medical Genetics, Part A , cilt.194, sa.10, 2024 (SCI-Expanded, Scopus)

23. ARTHRITIS AND ITS CHARACTERISTICS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

YENİGÜN S., Ayla A. Y., YÜZBAŞIOĞLU M. B., Baspinar S. N., Karabicek A., Demirkol F., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

24. The Journey of a Patient with Psoriatic Arthritis: The Path from Diagnosis to Treatment

Azman F. N., Tanin K., Sacin E., Azman E., Rizaoglu M., Uc C., et al.

ARTHRITIS & RHEUMATOLOGY , ss.2208-2210, 2024 (SCI-Expanded, Scopus)

25. Evaluation of Medication Adherence of FMF Patients Transitioned from a Pediatric Clinic to an Adult Clinic: A Cross-sectional Study

AVCI F. Z., Azman F. N., Unsal E. S., UĞURLU S.

ARTHRITIS & RHEUMATOLOGY , ss.4142-4143, 2024 (SCI-Expanded, Scopus)

26. Long-Term Echocardiographic Findings in Idiopathic Recurrent Pericarditis Patients Treated with Anakinra

TOKER DİNÇER Z., Raimoglu D., YILMAZ ALARÇİN E., DAĞ A., Karup S., MELİKOĞLU M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.2279-2281, 2024 (SCI-Expanded, Scopus)

27. Canakinumab Treatment in Patients with Familial Mediterranean Fever: A Tertiary Center Experience

Simsek O. B., Ayla A., UĞURLU S.

ARTHRITIS & RHEUMATOLOGY , ss.4136-4137, 2024 (SCI-Expanded, Scopus)

28. Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review Anakinra bei idiopathischer rezidivierender Perikarditis: umfangreiche Fallserie und Literaturübersicht

Toker Dincer Z., Karup S., YILMAZ B. E., Corbali O., Azman F. N., MELİKOĞLU M., et al.

Zeitschrift fur Rheumatologie , cilt.83, sa.7, ss.587-596, 2024 (SCI-Expanded, Scopus)

29. Path to Diagnosis in Familial Mediterranean Fever (FMF)

Karup S., Polat D., Dincsoy E., Azman F. N., Cokrak M. E., Berkiten E., et al.

ARTHRITIS & RHEUMATOLOGY , ss.586-587, 2024 (SCI-Expanded, Scopus)

30. Novel use of interleukin-1 antagonists in male familial Mediterranean fever patients with infertility: Case series

Egeli B., Parlar K., Filiz B., Durucan I., UĞURLU S.

ARCHIVES OF RHEUMATOLOGY , sa.3, ss.474-475, 2024 (SCI-Expanded, Scopus, TRDizin)

31. Severity scores, damage indices, and the concept of the colchicine-resistant patient in familial Mediterranean fever

Er O., Akay H., Ozgozen M. E., Gulhan D., UĞURLU S.

MODERN RHEUMATOLOGY , sa.1, ss.7-16, 2024 (SCI-Expanded, Scopus)

32. Exploring S100A8/A9, neopterin, and MMP3 in familial Mediterranean fever

Kilinc O. C., AKDENİZ Y. S., Taskin Z., Karabulut M., Kaya A., BOLAYIRLI İ. M., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , sa.1, ss.93-100, 2024 (SCI-Expanded, Scopus)

33. Unprecedented coexistence of autoinflammatory myositis and chronic thrombosis with heterozygotic M694V mutation: An atypical presentation of familial Mediterranean fever

Bahar F., UĞURLU S.

MODERN RHEUMATOLOGY CASE REPORTS , cilt.8, ss.383-385, 2024 (ESCI, Scopus)

34. Factors triggering familial mediterranean fever attacks, do they really exist?

Parlar K., Ates M. B., Onal M. E., Bostancı E., Azman F. N., UĞURLU S.

Internal and Emergency Medicine , cilt.19, sa.4, ss.1007-1013, 2024 (SCI-Expanded, Scopus)

35. Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials

Kilic B., Ozturk A., Karup S., Hacioglu E., UĞURLU S.

RHEUMATOLOGY , sa.1, ss.22-31, 2024 (SCI-Expanded, Scopus)

36. Case report: Other autoinflammatory mutations in a patient with atypical familial Mediterranean fever symptoms

Hacıoglu E., Er O., Karup S., UĞURLU S.

International Journal of Rheumatic Diseases , cilt.27, sa.4, 2024 (SCI-Expanded, Scopus)

37. Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis

Kilic B., Guler Y., Azman F. N., Bostanci E., UĞURLU S.

RHEUMATOLOGY , cilt.63, ss.925-935, 2024 (SCI-Expanded, Scopus)

38. Fertilization, reproductive system, and pregnancy in familial Mediterranean fever: Clinical state of art

Er O., UĞURLU S.

MODERN RHEUMATOLOGY , cilt.34, ss.265-271, 2024 (SCI-Expanded, Scopus)

39. Comment on: Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis

KILIÇ B., Parlar K., UĞURLU S.

Rheumatology (United Kingdom) , cilt.63, sa.2, 2024 (SCI-Expanded, Scopus)

40. Anxiety and depression among patients with familial Mediterranean fever Angst und Depression bei Patienten mit familiärem Mittelmeerfieber

Kilinc O. C., Kilinc A., Azman F. N., Ardac S., Egeli B., DEMİREL Ö. F., et al.

Zeitschrift fur Rheumatologie , cilt.83, sa.Suppl 1, ss.236-241, 2024 (SCI-Expanded, Scopus)

41. The clinical role of anakinra in the armamentarium against familial Mediterranean fever

Parlar K., Ates M. B., Egeli B. H., UĞURLU S.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY , cilt.20, sa.5, ss.441-453, 2024 (SCI-Expanded, Scopus)

42. Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency

Ates M. B., Karup S., UĞURLU S.

REUMATISMO , cilt.75, sa.4, ss.225-228, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma

43. Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever-a large retrospective cohort study

Parlar K., Kilic B., UĞURLU S.

RHEUMATOLOGY , 2023 (SCI-Expanded, Scopus)

44. Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review

Kilinc O. C., UĞURLU S.

Autoimmunity Reviews , cilt.22, sa.12, 2023 (SCI-Expanded, Scopus)

45. A different presentation of tubulointerstitial nephritis and uveitis syndrome mimicking Sjögren's syndrome

Yilmaz R., MURT A., GÜRSES İ., UĞURLU S.

ARCHIVES OF RHEUMATOLOGY , cilt.38, sa.4, ss.659-661, 2023 (SCI-Expanded, Scopus, TRDizin)

46. Cancer incidence in Familial Mediterranean Fever: A retrospective analysis.

Baspinar S. N., KILIÇ B., Azman F. N., Guler Y., Gunay U. B., Tanin M. K., et al.

Seminars in arthritis and rheumatism , cilt.63, ss.152284, 2023 (SCI-Expanded, Scopus)

47. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus)

48. Cancer Incidence in Familial Mediterranean Fever

Baspinar S. N., Kilic B., Azman F., YÜZBAŞIOĞLU M. B., Guler Y., Tanin M. K., et al.

ARTHRITIS & RHEUMATOLOGY , ss.263-265, 2023 (SCI-Expanded, Scopus)

49. Paternal Effects of Anti-TNFs in Inflammatory Arthritis

TOKER DİNÇER Z., Ates B., DAĞ A., TÜRKOĞLU İ., Ayla A. Y., UĞURLU S.

ARTHRITIS & RHEUMATOLOGY , ss.2647-2648, 2023 (SCI-Expanded, Scopus)

50. Comparison of telerehabilitation methods for patients with systemic sclerosis in the COVID-19 Era: A randomized controlled study

ÇİVİ KARAASLAN T., TARAKCI E., Keles O., Aslan Keles Y., UĞURLU S.

Journal of Hand Therapy , cilt.36, sa.4, ss.751-769, 2023 (SCI-Expanded, Scopus)

51. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience

Oztas M., Altun I., Ayla A. Y., Cerme E., Demirdag C., ASA S., et al.

International Journal of Rheumatic Diseases , cilt.26, sa.9, ss.1714-1721, 2023 (SCI-Expanded, Scopus)

52. Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype

Onen M. O., ONAT U. İ., Ugurlu S., TİMUÇİN A. C., ÖZ ARSLAN D., Everest E., et al.

RHEUMATOLOGY , cilt.62, sa.9, ss.3188-3196, 2023 (SCI-Expanded, Scopus)

53. A Different Presentation of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome mimicking Sjogren's Syndrome

Yilmaz R., Murt A., Gurses I., UĞURLU S.

SWISS MEDICAL WEEKLY , 2023 (SCI-Expanded, Scopus)

54. A review of rheumatoid meningitis with case studies.

Aktan Suzgun M., Erener N., Cavus G. H., Ozdede A., Guner S., UĞURLU S., et al.

Modern rheumatology case reports , cilt.7, sa.2, ss.340-346, 2023 (ESCI)

55. CARDIOVASCULAR DISEASES IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER OVER 50 YEARS OF AGE

Karup S., Ayci B., Baspinar S. N., Azman F. N., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , ss.1161-1162, 2023 (SCI-Expanded, Scopus)

56. PSYCHOMETRIC PROPERTIES OF SCREENING INSTRUMENTS FOR PSORIATIC ARTHRITIS

Ozdede A., Ayan G., Can G., Bektas M., Akdogan N., Solak E. O., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1796-1797, 2023 (SCI-Expanded, Scopus)

57. ANXIETY AND DEPRESSION IN PATIENTS WITH FMF

Egeli B., Kilinc O., Kilinc A., Azman F. N., Ardac S., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , ss.1985, 2023 (SCI-Expanded, Scopus)

58. TOCILIZUMAB TREATMENT IN SEVERE AND REFRACTORY BEHCET'S SYNDROME: A CASE SERIES

Dincer Z. T., Yurttas B., Esatoglu S. N., Ucar D., Uygunoglu U., UĞURLU S., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1571, 2023 (SCI-Expanded, Scopus)

59. The First Case Report of 47,XXY/46,XX/46,XY Mosaic Klinefelter Syndrome Patient With Mixed Connective Tissue Disorder

KALAYCI YİĞİN A., Alay M. T., UĞURLU S., SEVEN M.

American Journal of Men's Health , cilt.17, sa.3, 2023 (SSCI, Scopus)

60. Post-COVID-19 vaccination inflammatory syndrome: A case report.

Durucan I., Guner S., Kilickiran Avci B., Unverengil G., MELİKOĞLU M., UĞURLU S.

Modern rheumatology case reports , cilt.7, sa.1, ss.280-282, 2023 (ESCI)

61. Screening of antigliadin and antitissue transglutaminase antibodies in patients with chronic plaque psoriasis: a case-control study

ENGİN B., Hüseynova Ç., Ak T., Ayla A. Y., Can G., UĞURLU S.

Turkish Journal of Medical Sciences , cilt.53, sa.2, ss.544-551, 2023 (SCI-Expanded, Scopus, TRDizin)

62. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.

RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Familial Mediterranean fever: clinical state of the art

Egeli B. H., UĞURLU S.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE , cilt.115, sa.11, ss.711-718, 2022 (SCI-Expanded, Scopus)

64. Appendicitis Still a Challenge for FMF Patients?

Baspinar S. N., Alkan A., YÜZBAŞIOĞLU M. B., Yenigun S., Ayla A. Y., Durucan I., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3633-3634, 2022 (SCI-Expanded, Scopus)

65. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., TÜKEK N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus)

66. Characteristics of Arthritis in Familial Mediterranean Fever Patients

Ayla A. Y., YENİGÜN S., Baspinar S. N., YÜZBAŞIOĞLU M. B., Alkan A., Durucan I., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3618-3619, 2022 (SCI-Expanded, Scopus)

67. Canakinumab Treatment in Familial Mediterranean Fever Patients with Colchicine Resistance: A Single-center Study

Durucan I., Ayla A. Y., Besiroglu H. I., Alkan A., SELVİ O., Ozdogan H., et al.

ARTHRITIS & RHEUMATOLOGY , ss.3623-3625, 2022 (SCI-Expanded, Scopus)

68. Assessment of the Transition of Care from Pediatric to Adult Rheumatology in a Tertiary Center

UĞURLU S., Ayla A. Y., Besiroglu H. I., Azman F. N., Egeli B., Eren H., et al.

ARTHRITIS & RHEUMATOLOGY , ss.2565-2567, 2022 (SCI-Expanded, Scopus)

69. Late-onset familial mediterranean fever: single-center experience and literature review

Aydin O., Egeli B. H., Ozdogan H., UĞURLU S.

Internal and Emergency Medicine , cilt.17, sa.5, ss.1301-1306, 2022 (SCI-Expanded, Scopus)

70. An unusual sacral joint localization of granulomatosis with polyangiitis detected by [F-18]FDG PET/CT

Akgun E., Halac M., UĞURLU S., SÖNMEZOĞLU K.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.41, sa.4, ss.261-263, 2022 (SCI-Expanded, Scopus)

71. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine

ÖZTAŞ M., BEKTAŞ M., KARACAN İ., Aliyeva N., DAĞ A., Aghamuradov S., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.7, ss.3431-3437, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. An unusual sacral joint localization of granulomatosis with polyangiitis detected by [18F]FDG PET/CT Una localización inusual de granulomatosis con poliangitis en la articulación sacra detectada por la PET/TC con [18F]FDG

Akgun E., Halac M., UĞURLU S., SÖNMEZOĞLU K.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.41, sa.4, ss.261-263, 2022 (SCI-Expanded, Scopus)

73. Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors

UĞURLU S., Akcin R., Ayla A. Y., KOCAZEYBEK B. S., ÖZTAŞ M., CAN G., et al.

RHEUMATOLOGY , cilt.61, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

Ozdede A., GÜNER S., Ozcifci G., YURTTAŞ B., TOKER DİNCER Z., Atli Z., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, ss.973-987, 2022 (SCI-Expanded, Scopus)

75. SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET'S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER

Ozdede A., Guner S., Ozcifci G., Yurttas B., Dincer Z. T., Atli Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.962-963, 2022 (SCI-Expanded, Scopus)

76. THE MYSTERY OF FAMILIAL MEDITERRANEAN FEVER: IS THERE ANY FACTOR TRIGGERING THE ATTACKS?

Baspinar S. N., Durucan I., Yuzbasioglu M. B., Yenigun S., Ayla A. Y., Alkan A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1767-1768, 2022 (SCI-Expanded, Scopus)

77. AWARENESS OF BIOLOGICAL AGENTS RELATED SIDE EFFECTS AMONG INTERNAL MEDICINE RESIDENTS IN A UNIVERSITY HOSPITAL

Oztas M., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1854, 2022 (SCI-Expanded, Scopus)

78. DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF PATIENTS WITH FMF?

Oztas M., Selvi O., Ergezen B., Ozdogan H., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1840-1841, 2022 (SCI-Expanded, Scopus)

79. FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE

Oztas M., Bektas M., Karacan I., Aliyeva N., Dag A., Aghamuradov S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1660-1661, 2022 (SCI-Expanded, Scopus)

80. A NEW SCREENING TOOL FOR PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS: TURPAS

AYAN G., Hatemi G., Can G., Bektas M., Ozdede A., Akdogan N., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1597-1598, 2022 (SCI-Expanded, Scopus)

81. A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHCET'S SYNDROME

Karatemiz G., Esatoglu S. N., Gurcan M., Ozguler Y., Yurdakul S., Hamuryudan V., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1758-1759, 2022 (SCI-Expanded, Scopus)

82. OUTCOME OF VASCULAR INVOLVEMENT OF BEHCET'S SYNDROME TREATED WITH INFLIXIMAB: A RETROSPECTIVE COHORT STUDY

Hatemi G., Tukek B., Esatoglu S. N., Ozguler Y., Taflan S. S., Melikoglu M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.696-697, 2022 (SCI-Expanded, Scopus)

83. COMPARISON OF TELEREHABILITATION METHODS FOR SYSTEMIC SCLEROSIS PATIENTS IN THE COVID-19 ERA: A RANDOMIZED CONTROLLED STUDY

Karaaslan T. C., TARAKCI E., Keles O., Keles Y. A., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1850, 2022 (SCI-Expanded, Scopus)

84. Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report

ÇERME E., ÖZTAŞ M., BALKAN İ. İ., Cetin E. A., UĞURLU S.

MODERN RHEUMATOLOGY CASE REPORTS , cilt.6, sa.1, ss.140-144, 2022 (ESCI, Scopus) Sürdürülebilir Kalkınma

85. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behcet's syndrome

Ozcifci G., Aydin T., Atli Z., BALKAN İ. İ., TABAK Ö. F., ÖZTAŞ M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.101-113, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

86. Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective single-center cohort study

Egeli B. H., Ergun S., Cetin A., Gursoy Y. K., UĞURLU S.

CLINICAL RHEUMATOLOGY , cilt.41, sa.1, ss.123-127, 2022 (SCI-Expanded, Scopus)

87. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center

Oztas M., Ozgul H., Seyahi E., Ugurlu S.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.917-925, 2022 (SCI-Expanded, Scopus, TRDizin)

88. Idiopathic granulomatous mastitis associated with erythema nodosum may indicate a worse prognosis

VELİDEDEOĞLU M., PAPİLA KUNDAKTEPE B., METE B., UĞURLU S.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.24, sa.11, ss.1370-1377, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. CAUSES OF HOSPITALIZATION IN BEHCET SYNDROME

Ozguler Y., Hatemi G., Pala A. S., Esatoglu S. N., UĞURLU S., SEYAHİ E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.958, 2021 (SCI-Expanded, Scopus)

90. INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHCET SYNDROME

Hatemi G., Tukek B., Esatoglu S. N., Ozguler Y., Melikoglu M., Caliskan E. B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.663, 2021 (SCI-Expanded, Scopus)

91. INSTRUMENTS FOR SCREENING PSORIATIC ARTHRITIS AMONG PATIENTS WITH PSORIASIS: A SYSTEMATIC LITERATURE REVIEW

Can G., Ayan G., Ozdede A., BEKTAŞ M., Akdogan N., Yalici-Armagan B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1327, 2021 (SCI-Expanded, Scopus)

92. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

YURTTAŞ B., POYRAZ B. Ç., SÜT N., Ozdede A., ÖZTAŞ M., UĞURLU S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.6, ss.1105-1114, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

93. ADULT-ONSET STILL'S DISEASE: A SINGLE-CENTER EXPERIENCE

Egeli B., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.966, 2021 (SCI-Expanded, Scopus)

94. BIOLOGIC TREATMENT OF ADULT-ONSET STILL'S DISEASE: A SINGLE CENTER EXPERIENCE

Yurttas B., Egeli B., Ozkose G. G., UĞURLU S.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.974, 2021 (SCI-Expanded, Scopus)

95. Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience

UĞURLU S., Ergezen B., Egeli B. H., SELVİ O., Ozdogan H.

RHEUMATOLOGY , cilt.60, sa.5, ss.2327-2332, 2021 (SCI-Expanded, Scopus)

96. COVID-19 Among Patients With Inflammatory Rheumatic Diseases

Esatoglu S. N., Tascilar K., Babaoglu H., Bes C., YURTTAŞ B., AKAR S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

97. A rare case of an NLRP12-associated autoinflammatory disease

Ayla A. Y., Eren H., Zare J., Calhan S. S., KARACAN İ., Seven M., et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS , cilt.64, sa.4, 2021 (SCI-Expanded, Scopus)

98. Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis

Ugurlu S., Egeli B. H., Bolayirli I. M., Ozdogan H.

IMMUNOLOGICAL INVESTIGATIONS , cilt.50, sa.2-3, ss.273-281, 2021 (SCI-Expanded, Scopus)

99. The Prevalence of Familial Mediterranean Fever and Behcet's Disease: A Cross-Sectional Study

ALPARSLAN Ö., Egeli B. H., DEMİREL Y., Ugurlu S.

ARCHIVES OF RHEUMATOLOGY , cilt.35, sa.4, ss.609-613, 2020 (SCI-Expanded, Scopus, TRDizin)

100. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever

UĞURLU S., Ergezen B., Egeli B. H., Selvi O., Ozdogan H.

Rheumatology (Oxford, England) , cilt.59, sa.12, ss.3892-3899, 2020 (SCI-Expanded, Scopus)

101. Comment on: Serum Strem-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course

Ugurlu S., Egeli B. H.

RHEUMATOLOGY , cilt.59, sa.11, 2020 (SCI-Expanded, Scopus)

102. Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin

Uzuncakmak T. K., Bayazit S., Askin Ö., Engin B., Ugurlu S., Sar M., et al.

Dermatologic Therapy , cilt.33, sa.6, 2020 (SCI-Expanded, Scopus)

103. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis

Ozdogan H., Ugurlu S., Uygunoglu U., Tutuncu M., Gul A., Akman G., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.45, 2020 (SCI-Expanded, Scopus)

104. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M., Esatoglu S. N., Hamuryudan V., Saygin D., Ugurlu S., Seyahi E., et al.

Rheumatology (Oxford, England) , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded, Scopus)

105. In Familial Mediterranean Fever, soluble TREM-1 plasma level is higher in case of amyloidosis

UĞURLU S., Egeli B. H.

INNATE IMMUNITY , cilt.26, sa.3, ss.231, 2020 (SCI-Expanded, Scopus)

106. Comment on: Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome: Reply

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.

Rheumatology (United Kingdom) , cilt.59, sa.4, ss.914-915, 2020 (SCI-Expanded, Scopus)

107. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.

Rheumatology (United Kingdom) , cilt.59, sa.4, ss.799-806, 2020 (SCI-Expanded, Scopus)

108. Takayasu's arteritis: associated inflammatory diseases

Esatoglu S. N., Ok A. M., Ucar D., Celik A. F., Ugurlu S., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.2, 2020 (SCI-Expanded, Scopus)

109. Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey

Erdogan M., Ugurlu S., Ozdogan H., Seyahi E.

Clinical and experimental rheumatology , cilt.37, sa.6, ss.119-124, 2019 (SCI-Expanded, Scopus)

110. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study

Karacan İ., Balamir A., Ugurlu S., Aydin A. K., Everest E., Zor S., et al.

RHEUMATOLOGY INTERNATIONAL , sa.5, ss.911-919, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Polyarteritis nodosa: lessons from 25 years of experience

SÖNMEZ H., ARMAĞAN B., Ayan G., Barut K., Batu E. D., Erden A., et al.

Clinical and experimental rheumatology , cilt.37, sa.2, ss.52-56, 2019 (SCI-Expanded, Scopus)

112. Familial Mediterranean Fever

OZDOGAN H., Ugurlu S.

PRESSE MEDICALE , cilt.48, sa.1, 2019 (SCI-Expanded, Scopus)

113. Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with Familial Mediterranean Fever ?

Ugurlu S., Selvi O., Ergezen B., Ozdogan H.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

114. Canakinumab Treatment in Adult-Onset Still's Disease: Case Series

UĞURLU S., Guzelant G., Yurttas B., Ergezen B., DALKILIÇ H. E., KAŞİFOĞLU T., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

115. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

116. Anakinra Treatment in Refractory Cases of Adult-Onset Still Disease: Case Series

UĞURLU S., Yurttas B., Guzelant G., Ergezen B., Ozdogan H.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

117. Anti-Il-1 Therapies in Patients with Familial Mediterranean Fever Related AA-Amyloidosis

Ergezen B., Ugurlu S., Selvi O., Egeli B. H., Ozdogan H.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

118. LACC1 Gene Defects in Familial Form of Juvenile Arthritis

Karacan İ., Ugurlu S., Sahin S., Everest E., Kasapcopur O., Tolun A., et al.

JOURNAL OF RHEUMATOLOGY , sa.5, ss.726-728, 2018 (SCI-Expanded, Scopus)

119. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus)

120. DERMATOMYOSITIS ASSOCIATED WITH PAPILLARY THYROID CANCER: A CASE REPORT AND REVIEW OF LITERATURE

Ugurlu S., Yilmaz U., Ozdogan H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

121. An update on pulmonary artery involvement in Behcet's syndrome: more pulmonary artery thrombotic disease and a better outcome

Ozguler Y., Dincses E., Bakan S., Hatemi G., Melikoglu M., Ugurlu S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

122. Retrospective analysis of initial presentation findings of Behcet's syndrome throughout 4 decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

123. Factors associated with damage progression in Behcet's syndrome uveitis

Ozyazgan Y., Ucar D., ERDOĞAN M., Ozguler Y., Gulen G., Sebahattin S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

124. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency

Sahin S., Adrovic A., Barut K., Ugurlu S., Turanli E. T., Ozdogan H., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.1, ss.129-136, 2018 (SCI-Expanded, Scopus)

125. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M., et al.

RHEUMATOLOGY , cilt.56, ss.2102-2108, 2017 (SCI-Expanded, Scopus)

126. C-Reactive Protein and Serum Amyloid a in Sepsis, Acute Appendicitis and Familial Mediterranean Fever

Selvi O., Ugurlu S., Bolayirli M., Barut K., Sahin S., Adrovic A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

127. Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.

Esatoglu S. N., Hatemi G., Ugurlu S., Gokturk A., Tascilar K., Ozdogan H.

Medicine , cilt.96, sa.34, 2017 (SCI-Expanded, Scopus)

128. Myelopathy in Behçet's disease: The Bagel Sign

Uygunoglu U., Zeydan B., Ozguler Y., Ugurlu S., Seyahi E., Kocer N., et al.

Annals of Neurology , cilt.82, sa.2, ss.288-298, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

129. Atorvastatin-induced dermatomyositis

Oztas M., Ugurlu S., Aydin Ö.

RHEUMATOLOGY INTERNATIONAL , cilt.37, sa.7, ss.1217-1219, 2017 (SCI-Expanded, Scopus)

130. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever

Ugurlu S., Hacioglu A., Adibnia Y., Hamuryudan V., Ozdogan H.

ORPHANET JOURNAL OF RARE DISEASES , cilt.12, 2017 (SCI-Expanded, Scopus)

131. **Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF**

Karacan İ., Ugurlu S., Tolun A., Turanli E. T., Ozdogan H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.6, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

132. Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes

SENYIGIT A., Tabak O., ORBANOGLU T., Karadag A., Ugurlu S., Uzun H., et al.

Clinical and Investigative Medicine , cilt.40, sa.5, 2017 (SCI-Expanded, Scopus)

133. Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journals

Yurdakul S., Ayan G., Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., et al.

European Journal of Internal Medicine , cilt.37, 2017 (SCI-Expanded, Scopus)

134. Canakinumab for the treatment of familial Mediterranean fever

Ozdogan H., Ugurlu S.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY , cilt.13, sa.5, ss.393-404, 2017 (SCI-Expanded, Scopus)

135. Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci Ş., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.36, sa.12, ss.1719-1725, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

136. Effect of colchicine on serum lipid levels

Ugurlu S., Seyahi E., Hanci I., PEHLEVAN S., Ozdogan H., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

137. OSTEOPONTIN LEVELS AND OTHER IN OCULAR BEHCET'S DISEASE: A CONTROLLED STUDY

Tuzcu A., Ugurlu S., Ozyazgan Y., Andican G., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.6, 2016 (SCI-Expanded, Scopus)

138. BEHCET'S SYNDROME ASSOCIATED WITH TAKAYASU'S ARTERITIS: A CASE SERIES OF 10 PATIENTS

Esatoglu S. N., Seyahi E., Ugurlu S., Hatemi G., Melikoglu M., Hamuryudan V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

139. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet's syndrome patients with pulmonary artery involvement during follow-up

Esatoglu S. N., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

140. Infliximab is a plausible alternative for neurologic complications of Behcet disease

Zeydan B., Uygunoglu U., Saip S., Demirci O. N., Seyahi E., Ugurlu S., et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.3, sa.5, 2016 (SCI-Expanded, Scopus)

141. ANTI-Interleukin 1 Therapy in FMF Amyloidosis: A Single Center Experience

Ugurlu S., Ergezen B., Ozdogan H.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

142. A NOVEL Missense Mvk mutation in a Family with Familial Mediterranean Fever-like Disease

Karacan I., Ugurlu S., TOLUN A., Tahir Turanlı E., Ozdogan H.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

143. Associated Inflammatory Diseases in Takayasu's Arteritis: The Many Faces of a Disease

Esatoglu S. N., Celik A. M., UÇAR D., Celik A. F., UĞURLU S., HATEMİ G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

144. Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients

Guzelant G., Melikoglu M., Musellim B., Yilmaz D. D., Fresko I., Seyahi E., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

145. Granulomatosis Polyangiitis Presenting With Bilateral Serous Otitis Media, Unilateral Facial Paralysis And Parotitis, Early Diagnosis And Follow Up

BATIOĞLU KARAALTIN A., Gluyev J., ALASKAROV E., UĞURLU S., KARAMAN E.

ENTcase , 2016 (TRDizin)

146. Pulmonary artery involvement in Behçet's syndrome: Effects of anti-Tnf treatment

Hamuryudan V., Seyahi E., Ugurlu S., Melikoglu M., Hatemi G., Ozguler Y., et al.

Seminars in Arthritis and Rheumatism , cilt.45, sa.3, ss.369-373, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Fatigue is correlated with disease activity but not with the type of organ involvement in Behcet's syndrome: a comparative clinical survey

Buyuktas D., Hatemi G., Yuksel-Findikoglu S., Ugurlu S., Yazici H., Yurdakul S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)